0001140361-14-001183.txt : 20140107 0001140361-14-001183.hdr.sgml : 20140107 20140107173011 ACCESSION NUMBER: 0001140361-14-001183 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140107 FILED AS OF DATE: 20140107 DATE AS OF CHANGE: 20140107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NATIONAL RESEARCH CORP CENTRAL INDEX KEY: 0000070487 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 470634000 STATE OF INCORPORATION: WI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 BUSINESS PHONE: 4024752525 MAIL ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karas Kevin R CENTRAL INDEX KEY: 0001522907 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35929 FILM NUMBER: 14514373 MAIL ADDRESS: STREET 1: C/O NATIONAL RESEARCH CORPORATION STREET 2: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 4 1 doc1.xml FORM 4 X0306 4 2014-01-07 0 0000070487 NATIONAL RESEARCH CORP NRCIA/B 0001522907 Karas Kevin R C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 0 1 0 0 SVP Finance, CFO, Treas & Secy Class A Common Stock 20892 D Class B Common Stock 3482 D Employee Stock Option (right to buy) 18.8 2014-01-07 4 A 0 5334 0 A 2024-01-07 Class A Common Stock 5334 5334 D Employee Stock Option (right to buy) 34.15 2014-01-07 4 A 0 489 0 A 2024-01-07 Class B Common Stock 489 489 D Employee Stock Option (right to buy) 10.75 2022-01-05 Class A Common Stock 26403 26403 D Employee Stock Option (right to buy) 14.5 2023-01-07 Class A Common Stock 20088 20088 D Employee Stock Option (right to buy) 21.5 2022-01-05 Class B Common Stock 4400 4400 D Employee Stock Option (right to buy) 27.13 2023-01-07 Class B Common Stock 3348 3348 D On May 22, 2013, the Issuer completed a recapitalization pursuant to which it, among other things, issued a stock dividend of three shares of class A common stock for each share of then-existing common stock and reclassified each share of its then-existing common stock as one-half of one share of class B common stock. All fractional shares of class B common stock were cashed-out in the recapitalization. In connection with the recapitalization, the exercise prices of outstanding options were equitably adjusted to prevent the dilution or enlargement of the benefits intended to be provided. This option becomes fully exercisable on January 7, 2019. This option becomes fully exercisable on January 5, 2017. This option becomes fully exercisable on January 7, 2018. /s/ Russell E. Ryba, Attorney-in-Fact for Kevin R. Karas 2014-01-07